PolyNovo Limited (ASX:PNV) Insider Sells A$130,900.00 in Stock

PolyNovo Limited (ASX:PNV) insider Andrew Lumsden sold 50,000 shares of PolyNovo stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of A$2.62 ($1.81), for a total value of A$130,900.00 ($90,275.86).

PolyNovo Stock Performance

The company has a debt-to-equity ratio of 21.32, a quick ratio of 1.58 and a current ratio of 3.41.

About PolyNovo

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.